An Open-label Trial of Glivec in Patients With Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors Expressing C-kit.
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 08 Feb 2012 Actual end date (1 Jul 2008) added as reported by ClinicalTrials.gov.
- 08 Aug 2006 New trial record.